What are the benefits of Nanotechnology in TB drug delivery?
One of the major challenges in TB treatment is ensuring the efficient delivery of drugs to the site of infection. Nanotechnology can enhance drug delivery through the development of nanocarriers that improve the bioavailability and targeted delivery of antitubercular drugs. These carriers, such as liposomes, dendrimers, and polymeric nanoparticles, can encapsulate drugs, protecting them from degradation and ensuring controlled release. This targeted approach minimizes side effects and reduces the dosage frequency, improving patient adherence to treatment regimens.
